The Selective Peroxisome Proliferator-Activated Receptor-Delta Agonist Seladelpar Reverses Nonalcoholic Steatohepatitis Pathology by Abrogating Lipotoxicity in Diabetic Obese Mice
Citation
Haczeyni, F, Wang, H, Barn, V et al. 2017, 'The Selective Peroxisome Proliferator-Activated Receptor-Delta Agonist Seladelpar Reverses Nonalcoholic Steatohepatitis Pathology by Abrogating Lipotoxicity in Diabetic Obese Mice', Hepatology Communications, vol. 1, no. 7, pp. 663-674.Year
2017Field of Research
- Gastroenterology And Hepatology
